While foreign investors have been reducing their exposure to Indian pharma, some leading domestic institutional investors ...
Product has patent protection through 2044 - - Expected to be listed in the U.S. Food and Drug Administration's (FDA) Orange Book upon the product's approval - DEER PARK, Ill., Feb. 07, 2025 (GLOBE ...
A clinical trial comparing a one-page medication handout proposed by the U.S. Food and Drug Administration (FDA) with an ...
Government Initiatives and Expanding Access to Medication-Assisted Treatment (MAT) Drive Growth in Opioid Use Disorder (OUD) MarketAustin, United States, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Opioid Use ...